Author Archive: BIOtechNOW Editor

Biofuel Research at UC San Diego

abcs

A recent report by the US Department of Energy’s Bioenergy Technologies Office (BETO) ranked programs at UC San Diego as the two best in the country for algal biofuels research, including Scripps Institution of Oceanography as top in the nation. For the 28 Algae Technology Area projects reviewed by the panel, Mark Hildebrand and his team at Scripps Institution of Oceanography at UC San Diego were ranked the highest for criteria that included technical progress, Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Bio-fueling the Navy

shutterstock_26191726

The research component is anchored by the renowned biotech programs at University of California San Diego (UCSD), the Salk Institute and Scripps Research, which make San Diego a hotbed of biotech innovation. These institutions concentrate biologists, biotech scientists, engineers, and specialists, who in turn attract the entrepreneurs that help convert the research into products and companies. However, it also takes real marketplace demand—often led by a few significant “early adopters”—to put a new technology to Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Seek and Destroy

shutterstock_27160801

Ubiquibodies combine the specificity of antibodies with the destruction signal of ubiquitinization. Stand by for targeted destruction of disease-causing proteins in the cell Proteins in a cell that are aged or otherwise damaged are recycled via the ubiquitin-proteasome pathway (UPP). The doomed protein is first tagged with a protein called ubiquitin, which acts like a molecular sign reading “destroy me”, and then broken down by the proteasome, which is the cell’s recycling center. This catabolism Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Journey from the Bench to Bedside

shutterstock_2103563

A partnership between a leading academic research center and a biologics company is aiming to develop new therapeutic opportunities Translational research enables therapies get to where they need to be – to the patient. The process is characterized by collaborative activity between university and company scientists. One recent example is the announcement of a three-year collaboration between MedImmune, the global biologics research and development arm of AstraZeneca, and the Clinical and Translational Science Institute (CTSI) Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Expand Investment in Basic Research Needed to Advance Medical Progress

Michael Coburn

In 2007, the Napier and Lane families struggled to find answers to their daughters’ developmental problems, which included impaired communication and socialization skills. Both of the girls had a disorder so rare that it subsequently became identified only by the name of the small fragment of chromosome 16 that was missing, namely “16p11.2 deletion syndrome.” Dan Pinkel and Joe Gray, researchers at the University of California, San Francisco developed microarray comparative genomic hybridization, a technology Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,